Vancouver, Canada

Alexander Laurence Mandel

This inventor holds 12 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Zymeworks Inc., Zymeworks Bc Inc., Abdera Therapeutics Inc.. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Laurence Mandel. Retrieved from https://idiyas.com/inventor/alexander-laurence-mandel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: **Alexander Laurence Mandel: Innovator in Cytotoxic Compounds**

Introduction

Alexander Laurence Mandel, a prolific inventor based in Vancouver, Canada, holds an impressive portfolio of ten patents. His innovative contributions primarily focus on the development of cytotoxic and anti-mitotic compounds, showcasing his dedication to advancing pharmaceutical science.

Latest Patents

Mandel’s latest patents involve groundbreaking compounds that exhibit cytotoxic and anti-mitotic activity. These patents describe the methods associated with the preparation and use of such compounds, along with the pharmaceutical compositions that incorporate them. Notably, the disclosed compositions feature a unique structure represented as (T)-(L)-(D), where (T) is a targeting moiety, (L) is an optional linker, and (D) represents a compound manifesting cytotoxic and/or anti-mitotic activity. This innovation is poised to enhance targeted therapies in the treatment of various diseases.

Career Highlights

Throughout his career, Alexander Mandel has made significant strides in the field of biotechnology. He has worked with leading companies, including Zymeworks Inc. and Zymeworks BC Inc., where he has honed his skills and expanded his expertise in the development of pharmaceutical solutions. His contributions to these organizations have played a vital role in their research and development efforts.

Collaborations

Mandel has collaborated with a team of talented professionals, including Geoffrey C. Winters and James R. Rich. These partnerships have been instrumental in the ideation and execution of innovative projects, leveraging each individual's strengths to achieve shared goals in the realm of pharmaceutical research.

Conclusion

In summary, Alexander Laurence Mandel stands out as a notable inventor in the pharmaceutical industry, with a focus on cytotoxic and anti-mitotic compounds. His extensive patent portfolio, combined with his career achievements and collaborations, underscores his commitment to innovation. With ongoing advancements in his research, Mandel is set to make a lasting impact in the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…